Scinai Immunotherapeutics SCNI
NASDAQ SCNI
$0.47 +0.03 (+6.82%)
At close: Nov 9, 2026 · 4:00 PM EST

Scinai Immunotherapeutics (SCNI) Current Leases (2019 - 2021)

Updated

Scinai Immunotherapeutics' Current Leases was $249,000 in Q4 2021, up 22.7% from $203,000 a year earlier.

Analysis

Scinai Immunotherapeutics (SCNI) Current Leases (2019 - 2021) Analysis & Trends

  • In earlier years, Current Leases was $203,000 in FY2020 (+1.0%) and $201,000 in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn -
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn -
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn -
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn -
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn -
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn -
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn -
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn -
10 Scinai Immunotherapeutics 112,563.86 -8.15 Mn -1.25 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 249,000.00
Dec 31, 2020 203,000.00
Dec 31, 2019 201,000.00
API Access

Scinai Immunotherapeutics Current Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-leases&ticker=SCNI&period=max&api_key=YOUR_API_KEY